PDL Biopharma
PDLI
#8394
Rank
C$0.40 B
Marketcap
C$3.54
Share price
-8.52%
Change (1 day)
N/A
Change (1 year)

Earnings for PDL Biopharma (PDLI)

Earnings in 2020 (TTM): -C$0.18 Billion

According to PDL Biopharma 's latest financial reports the company's current earnings are C$80.61 Million. In 2019 the company made an earning of -C$89.4 Million a decrease over its 2018 earnings that were of -C$62.77 Million.

Earnings history for PDL Biopharma from 2001 to 2020

Annual earnings

Year Earnings Change
2020 (TTM)-C$0.18 Billion98.55%
2019-C$89.4 Million42.43%
2018-C$62.77 Million-121.38%
2017C$0.29 B60.41%
2016C$0.18 B-77.09%
2015C$0.79 B3.09%
2014C$0.77 B26.65%
2013C$0.61 B19.82%
2012C$0.51 B3.68%
2011C$0.49 B77.17%
2010C$0.27 B-35.29%
2009C$0.42 B23.45%
2008C$0.34 B-1751.42%
2007-C$21.08 Million-88.56%
2006-C$0.19 Billion93.73%
2005-C$95.08 Million13.63%
2004-C$83.68 Million32.12%
2003-C$63.33 Million87.44%
2002-C$33.79 Million-302.45%
2001C$16.68 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$49.86 B-26,529.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$15.84 B-8,501.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.16 Billion-16.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
C$50.02 M-126.52%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Nektar Therapeutics
NKTR
-C$0.22 Billion 16.39%๐Ÿ‡บ๐Ÿ‡ธ USA